Aaron Ring Biography

Dr. Ring is a recognized leader in the field of protein engineering and in its use for targeting novel pathways of the immune system. He was a primary inventor of the core technologies of Ab Initio Biotherapeutics. Additionally, he invented several promising immunotherapeutic agents while at Stanford, most notably, high-affinity SIRPα variants, which represent another potentially transformative advance in cancer immunotherapy. Currently, he is the Robert T. McCluskey Yale Scholar and Assistant Professor of Immunobiology at the Yale School of Medicine. Prior to his training at Stanford, Dr. Ring received concurrent B.S. and M.S. degrees in Molecular Biophysics and Biochemistry at Yale University, where he was awarded the Paul Sigler Memorial Prize. He has additionally been named a Beckman Scholar and a Goldwater Scholar, and was awarded with a Ruth L. Kirschstein National Research Service Award in recognition of his work. He was selected as a member of the 2016 Forbes 30 under 30 list in Healthcare.

As a renowned expert and highly sought-after speaker, Aaron Ring's expertise is in high demand. To book Aaron Ring for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Aaron Ring's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Aaron Ring's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Aaron Ring for your next speaking engagement.